|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guo Z, Zhong JH, Jiang JH, Zhang J, Xiang
BD and Li LQ: Comparison of survival of patients with BCLC stage A
hepatocellular carcinoma after hepatic resection or transarterial
chemoembolization: A propensity score-based analysis. Ann Surg
Oncol. 21:3069–3076. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chun JM, Kwon HJ, Sohn J, Kim SG, Park JY,
Bae HI, Yun YK and Hwang YJ: Prognostic factors after early
recurrence in patients who underwent curative resection for
hepatocellular carcinoma. J Surg Oncol. 103:148–151. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu JC, Huang YH, Chau GY, Su CW, Lai CR,
Lee PC, Huo TI, Sheen IJ, Lee SD and Lui WY: Risk factors for early
and late recurrence in hepatitis B-related hepatocellular
carcinoma. J Hepatol. 51:890–897. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gupta PB, Chaffer CL and Weinberg RA:
Cancer stem cells: Mirage or reality? Nat Med. 15:1010–1012. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kucia M, Reca R, Miekus K, Wanzeck J,
Wojakowski W, Wieczorek Janowska A, Ratajczak J and Ratajczak MZ:
Trafficking of normal stem cells and metastasis of cancer stem
cells involve similar mechanisms: Pivotal role of the SDF-1-CXCR4
axis. Stem Cells. 23:879–894. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo Z, Li LQ, Jiang JH, Ou C, Zeng LX and
Xiang BD: Cancer stem cell markers correlate with early recurrence
and survival in hepatocellular carcinoma. World J Gastroenterol.
20:2098–2106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pang RW and Poon RT: Cancer stem cell as a
potential therapeutic target in hepatocellular carcinoma. Curr
Cancer Drug Targets. 12:1081–1094. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu Z, Hao X, Yan M, Yao M, Ge C, Gu J and
Li J: Cancer stem/progenitor cells are highly enriched in
CD133+CD44+ population in hepatocellular carcinoma. Int J Cancer.
126:2067–2078. 2010.PubMed/NCBI
|
|
10
|
Yamashita T, Honda M, Nakamoto Y, Baba M,
Nio K, Hara Y, Zeng SS, Hayashi T, Kondo M, Takatori H, et al:
Discrete nature of EpCAM+ and CD90+ cancer stem cells in human
hepatocellular carcinoma. Hepatology. 57:1484–1497. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai
P, Chu PW, Lam CT, Poon RT and Fan ST: Significance of CD90+ cancer
stem cells in human liver cancer. Cancer Cell. 13:153–166. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Haraguchi N, Ishii H, Mimori K, Tanaka F,
Ohkuma M, Kim HM, Akita H, Takiuchi D, Hatano H, Nagano H, et al:
CD13 is a therapeutic target in human liver cancer stem cells. J
Clin Invest. 120:3326–3339. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kondo T, Setoguchi T and Taga T:
Persistence of a small subpopulation of cancer stem-like cells in
the C6 glioma cell line. Proc Natl Acad Sci USA. 101:781–786. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Teshima K, Nara M, Watanabe A, Ito M,
Ikeda S, Hatano Y, Oshima K, Seto M, Sawada K and Tagawa H:
Dysregulation of BMI1 and microRNA-16 collaborate to enhance an
anti-apoptotic potential in the side population of refractory
mantle cell lymphoma. Oncogene. 33:2191–2203. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang J, Guo LP, Chen LZ, Zeng YX and Lu
SH: Identification of cancer stem cell-like side population cells
in human nasopharyngeal carcinoma cell line. Cancer Res.
67:3716–3724. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ho MM, Ng AV, Lam S and Hung JY: Side
population in human lung cancer cell lines and tumors is enriched
with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu XT, Xu Q, Tong JL, Zhu MM, Nie F, Chen
X, Xiao SD and Ran ZH: MicroRNA expression profiling identifies
miR-328 regulates cancer stem cell-like SP cells in colorectal
cancer. Br J Cancer. 106:1320–1330. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dubrovska A, Hartung A, Bouchez LC, Walker
JR, Reddy VA, Cho CY and Schultz PG: CXCR4 activation maintains a
stem cell population in tamoxifen-resistant breast cancer cells
through AhR signalling. Br J Cancer. 107:43–52. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yasuda K, Torigoe T, Morita R, Kuroda T,
Takahashi A, Matsuzaki J, Kochin V, Asanuma H, Hasegawa T, Saito T,
et al: Ovarian cancer stem cells are enriched in side population
and aldehyde dehydrogenase bright overlapping population. PLoS One.
8:e681872013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Van den Broeck A, Vankelecom H, Van Delm
W, Gremeaux L, Wouters J, Allemeersch J, Govaere O, Roskams T and
Topal B: Human pancreatic cancer contains a side population
expressing cancer stem cell-associated and prognostic genes. PloS
One. 8:e739682013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Marquardt JU, Raggi C, Andersen JB, Seo D,
Avital I, Geller D, Lee YH, Kitade M, Holczbauer A, Gillen MC, et
al: Human hepatic cancer stem cells are characterized by common
stemness traits and diverse oncogenic pathways. Hepatology.
54:1031–1042. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chiba T, Kita K, Zheng YW, Yokosuka O,
Saisho H, Iwama A, Nakauchi H and Taniguchi H: Side population
purified from hepatocellular carcinoma cells harbors cancer stem
cell-like properties. Hepatology. 44:240–251. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Goodell MA, Brose K, Paradis G, Conner AS
and Mulligan RC: Isolation and functional properties of murine
hematopoietic stem cells that are replicating in vivo. J Exp Med.
183:1797–1806. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu C and Alman BA: Side population cells
in human cancers. Cancer Lett. 268:1–9. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tang ZY, Ye SL, Liu YK, Qin LX, Sun HC, Ye
QH, Wang L, Zhou J, Qiu SJ, Li Y, et al: A decade's studies on
metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol.
130:187–196. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shi GM, Xu Y, Fan J, Zhou J, Yang XR, Qiu
SJ, Liao Y, Wu WZ, Ji Y, Ke AW, et al: Identification of side
population cells in human hepatocellular carcinoma cell lines with
stepwise metastatic potentials. J Cancer Res Clin Oncol.
134:1155–1163. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang FF, Zhang L, Wu DS, Yuan XY, Yu YH,
Zhao XL, Chen FP and Zeng H: PTEN regulates BCRP/ABCG2 and the side
population through the PI3K/Akt pathway in chronic myeloid
leukemia. PLoS One. 9:e882982014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang G, Wang Z, Luo W, Jiao H, Wu J and
Jiang C: Expression of potential cancer stem cell marker ABCG2 is
associated with malignant behaviors of hepatocellular carcinoma.
Gastroenterol Res Pract. 2013:7825812013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gagliardi A, Mullin NP, Ying TZ, Colby D,
Kousa AI, Halbritter F, Weiss JT, Felker A, Bezstarosti K, Favaro
R, et al: A direct physical interaction between Nanog and Sox2
regulates embryonic stem cell self-renewal. Embo J. 32:2231–2247.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Z, Oron E, Nelson B, Razis S and
Ivanova N: Distinct lineage specification roles for NANOG, OCT4 and
SOX2 in human embryonic stem cells. Cell Stem Cell. 10:440–454.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim MO, Kim S, Cho Y, Nadas J, Jeong C,
Yao K, Kim DJ, Yu D, Keum Y, Lee K, et al: ERK1 and ERK2 regulate
embryonic stem cell self-renewal through phosphorylation of Klf4.
Nat Struct Mol Biol. 19:283–290. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu C, Wei Q, Utomo V, Nadesan P, Whetstone
H, Kandel R, Wunder JS and Alman BA: Side population cells isolated
from mesenchymal neoplasms have tumor initiating potential. Cancer
Res. 67:8216–8222. 2007. View Article : Google Scholar : PubMed/NCBI
|
